Spirocyclic EBI2 modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10196369
APP PUB NO 20160176875A1
SERIAL NO

14910658

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are small molecule Epstein-Barr virus-induced G-protein coupled receptor 2 (EBI2) modulator compounds, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds. In some embodiments, EBI2 is a therapeutic target for the treatment of diseases or conditions such as, but not limited to, autoimmune diseases or conditions, cancer, and cardiovascular disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ardecky, Robert La Jolla, US 7 12
Ganji, Santhi Reddy La Jolla, US 3 4
Gonzalez-Lopez, Marcos La Jolla, US 14 8
Pinkerton, Anthony B San Diego, US 50 229
Sergienko, Eduard A San Diego, US 2 2
Zou, Jiwen San Diego, US 12 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 5, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 5, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00